Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 5 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant...
Centers for Disease Control and Prevention· 1 day agoVaccine Effectiveness among Household Contacts
Study sheds light on why some people do not get Covid-19
PA Media: Science via Yahoo News· 3 hours agoResearchers from the Wellcome Sanger Institute, University College London, Imperial College London,...
New tuberculosis vaccine candidate shows promise with post-translational modifications
Medical Xpress· 4 hours agoThe current anti-tuberculosis vaccine, BCG, is administered worldwide. As a result, the development of vaccines to replace BCG is underway. Actually, BCG ...
MSD competes with Pfizer in pneumococcal vaccine market after FDA approval
Pharmaceutical Technology via Yahoo Finance· 1 day agoMerck & Co (MSD) has won US Food and Drug Administration (FDA) approval for its 21-valent...
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
BioPharma Dive via Yahoo Finance· 1 day agoDive Brief: The Food and Drug Administration on Monday approved a new vaccine from Merck & Co. that...
6 Ways To Engineer Adenoviruses For Gene Therapy And Vaccines
Forbes· 14 hours agoSince their discovery in the 1950s, adenoviruses have been increasingly recognized as versatile and...
Merck's vaccine approval poses threat to one of Pfizer's top-selling products
Morningstar· 2 days agoMerck & Co. Inc. on Monday gained U.S. regulatory approval for a vaccine that could become a tough competitor to one of Pfizer Inc.'s top-selling products. The Food and Drug ...
What is bird flu and how worried should I be about a pandemic?
BBC via Yahoo News· 21 hours ago"Because [those birds] are the ones that one are very susceptible to this, and they seem to be the...
FDA approves 1st adult vaccine for bacterial pneumonia
Becker’s Hospital Review· 1 day ago"Merck receives FDA approval for Capvaxive, a new vaccine to protect adults from pneumococcus, a bacteria that can cause serious diseases like pneumonia."